UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000049321
Receipt No. R000056167
Scientific Title Investigation of optimal parameters for ideal perioperative management
Date of disclosure of the study information 2022/10/26
Last modified on 2022/10/26 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation of the relationship between food allergy and anesthetics
Acronym Investigation of the relationship between food allergy and anesthetics
Scientific Title Investigation of optimal parameters for ideal perioperative management
Scientific Title:Acronym Investigation of optimal parameters for ideal perioperative management
Region
Japan

Condition
Condition Food allergy
Classification by specialty
Clinical immunology Surgery in general Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine whether propofol increases the risk of allergic reactions in patients with food allergies.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes a relative risk of allergic reactions after propofol use for patients with egg/soybean allergy.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients who underwent surgery involving anesthesiologists from 1 January 2018 to 31 December 2021.
Key exclusion criteria Electroconvulsive therapy
Target sample size 160

Research contact person
Name of lead principal investigator
1st name Kanji
Middle name
Last name Uchida
Organization The University of Tokyo Hospital.
Division name Department of Anesthesiology and Pain Relief Center
Zip code 113-8655
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo
TEL +81338155411
Email uchidak-ane@h.u-tokyo.ac.jp

Public contact
Name of contact person
1st name Masaki
Middle name
Last name Iwakiri
Organization The University of Tokyo Hospital.
Division name Department of Anesthesiology and Pain Relief Center
Zip code 113-8655
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo
TEL +81338155411
Homepage URL
Email iwakirim-ane@h.u-tokyo.ac.jp

Sponsor
Institute The University of Tokyo.
Institute
Department

Funding Source
Organization self
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Research Ethics Committee of the Faculty of Medicine of the University of Tokyo
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033 JAPAN
Tel +813-5841-0818
Email ethics@m.u-tokyo.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 10 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 22111
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2022 Year 04 Month 01 Day
Date of IRB
2018 Year 11 Month 12 Day
Anticipated trial start date
2022 Year 05 Month 01 Day
Last follow-up date
2022 Year 05 Month 01 Day
Date of closure to data entry
2022 Year 05 Month 01 Day
Date trial data considered complete
2022 Year 05 Month 01 Day
Date analysis concluded
2022 Year 06 Month 01 Day

Other
Other related information Allergic reactions within 24 hours after propofol administration

Management information
Registered date
2022 Year 10 Month 26 Day
Last modified on
2022 Year 10 Month 26 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056167